← Back to headlines
Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares
17 Mar, 16:27 — 17 Mar, 16:27
Sources
Showing 1 of 1 sources
Related Stories
Colégio de Sexologia contra propostas de mudança de género
14m ago
Four held in Noida for operating racket by using fake health insurance cards meant for ex-servicemen
14m ago
EFPIA wants an increase in the European quota in clinical trials
15m ago
Brazil: Bolsonaro's health is improving - Still hospitalized in a private clinic
20m ago